Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organigram Global Inc. - Common Shares (NQ:OGI)

1.365 +0.025 (+1.87%)
Streaming Delayed Price Updated: 12:57 PM EDT, May 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Organigram Global Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Marijuana Stock Movers For May 21, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From May 19, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
This Week In Cannabis: Earnings Season, Uruguay's 'Pepe' Mujica's Legacy, DEA's Meme Backlash, California's Tax Hike, The DEA's Stance And More
Cannabis jobs fall while sales rise, Mujica's death sparks global reflection, and the DEA returns to old scare tactics. This week's top cannabis news. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Earnings Scheduled For May 12, 2025
Via Benzinga
Insights Ahead: OrganiGram Holdings's Quarterly Earnings
Via Benzinga
OrganiGram Holdings Earnings Review: Q4 Summary
Via Benzinga
Marijuana Stock Movers For May 12, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Lights Up Q2 With 74% Sales Surge, Profitable Turn
Organigram's Q2 sales surged 74% to $45.7 million, driven by Motif and global growth, with net income swinging to CA$42.5 million from a loss a year ago. 
Via Benzinga
Cannabis Stock Gainers And Losers From May 6, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
OrganiGram Holdings Q4 Earnings Assessment
Via Benzinga
Cannabis Stock Movers For April 24, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For April 23, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For April 22, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Pre-Rolls Are Cannabis' Most Profitable Format, From California To Canada
Pre-rolls dominate cannabis sales on both sides of the border—but California and Canada are playing very different games to win. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From April 11, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 9, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For April 7, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For April 4, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations
This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry transformation. 
Via Benzinga
Topics Government
Exposures Political
Cannabis Stock Movers For April 3, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
This Week In Cannabis: Gaetz's Stock Rally, Major Policy Battles, Homeland Security's Stance, Big Earnings And More
Cannabis news this week: Gaetz sparks cannabis stock rally, Homeland Security reaffirms seizures, key policy moves and major earnings shake the industry. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Big Tobacco's Latest $86.8 Million Cannabis Investment Signals Growing Industry Influence
British American Tobacco finalizes a C$124.6M investment in Organigram, reinforcing big tobacco's stake in cannabis. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For February 17, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram (OGI) Q1 2025 Earnings Call Transcript
OGI earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Cannabis Producer Organigram Q1 Sales Jump 17%, Expect C$10 Million From Motif Integration, Annual Run-Rate Synergies Within Two Years
Organigram's Q1 FY25 sales hit C$66.8M. Net revenue rose 17%, and adjusted EBITDA improved to C$1.4M. Cash position set to reach C$113M. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Earnings Scheduled For February 11, 2025
Via Benzinga
Bullish Wednesday For Marijuana Stocks - Cara Therapeutics, MPX International Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram (OGI) Q4 2024 Earnings Call Transcript
OGI earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Cannabis Player Organigram Clocks Q4 Gross Margin Of 37% On Higher Efficiency Across Cultivation And Higher Recreational Sales, Stock Soars
Organigram's Q4 sales hit $31.22 million, boosted by recreational and international growth, with adjusted gross margin improving to 37% of net revenue. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.